- Home
- MRNA vs RVTY Comparison
MRNA vs RVTY Comparison
Compare MRNA & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- RVTY
- Stock Information
- Founded
- MRNA 2010
- RVTY 1937
- Country
- MRNA United States
- RVTY United States
- Employees
- MRNA N/A
- RVTY N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- RVTY Biotechnology: Laboratory Analytical Instruments
- Sector
- MRNA Health Care
- RVTY Industrials
- Exchange
- MRNA Nasdaq
- RVTY Nasdaq
- Market Cap
- MRNA 10.9B
- RVTY 9.8B
- IPO Year
- MRNA 2018
- RVTY N/A
- Fundamental
- Price
- MRNA $25.87
- RVTY $87.13
- Analyst Decision
- MRNA Hold
- RVTY Buy
- Analyst Count
- MRNA 19
- RVTY 13
- Target Price
- MRNA $43.50
- RVTY $120.08
- AVG Volume (30 Days)
- MRNA 12.2M
- RVTY 1.2M
- Earning Date
- MRNA 11-06-2025
- RVTY 11-03-2025
- Dividend Yield
- MRNA N/A
- RVTY 0.33%
- EPS Growth
- MRNA N/A
- RVTY 72.56
- EPS
- MRNA N/A
- RVTY 2.37
- Revenue
- MRNA $3,078,000,000.00
- RVTY $2,798,467,000.00
- Revenue This Year
- MRNA N/A
- RVTY $5.55
- Revenue Next Year
- MRNA $10.17
- RVTY $4.26
- P/E Ratio
- MRNA N/A
- RVTY $36.06
- Revenue Growth
- MRNA N/A
- RVTY 3.33
- 52 Week Low
- MRNA $23.15
- RVTY $81.36
- 52 Week High
- MRNA $75.37
- RVTY $129.50
- Technical
- Relative Strength Index (RSI)
- MRNA 51.44
- RVTY 49.07
- Support Level
- MRNA $23.18
- RVTY $81.69
- Resistance Level
- MRNA $25.90
- RVTY $88.49
- Average True Range (ATR)
- MRNA 1.16
- RVTY 2.74
- MACD
- MRNA 0.27
- RVTY 0.19
- Stochastic Oscillator
- MRNA 95.05
- RVTY 63.29
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.